Literature DB >> 24651090

Dual infection of Mycoplasma pneumoniae and Chlamydophila pneumoniae in patients with atopic predispositions successfully treated by moxifloxacin.

Itsuro Kazama1, Toshiyuki Nakajima1.   

Abstract

We report two cases of dual infection with Mycoplasma pneumoniae and Chlamydophila pneumoniae complicated by atopic dermatitis or allergic rhinitis. After exacerbations of atopic eczema or rhinitis, both patients presented a nocturnal fever with persistent cough for more than two weeks. Although the use of susceptible antibiotics, such as minocycline or azithromycin, failed to work, moxifloxacin completely resolved their prolonged symptoms shortly after the administration together with a dramatic improvement of the atopic symptoms. Since the patients in question were predisposed to atopic disorders and their lymphocytes were hypersensitive, an immunological response was thought to be easily triggered by the organisms. Additionally, due to the lymphocyte-stimulatory nature of M. pneumoniae and C. pneumoniae, enhanced immunity was likely to be involved in the pathogenesis. The immunomodulatory property of moxifloxacin was thought to repress the increased lymphocyte activity, and thus facilitated complete remission of the disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24651090

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  3 in total

1.  Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases.

Authors:  Itsuro Kazama; Tsutomu Tamada; Masahiro Tachi
Journal:  Inflamm Res       Date:  2015-07-24       Impact factor: 4.575

Review 2.  Roles of lymphocyte kv1.3-channels in the pathogenesis of renal diseases and novel therapeutic implications of targeting the channels.

Authors:  Itsuro Kazama
Journal:  Mediators Inflamm       Date:  2015-03-18       Impact factor: 4.711

3.  Nonsteroidal Anti-Inflammatory Drugs Quickly Resolve Symptoms Associated with EBV-Induced Infectious Mononucleosis in Patients with Atopic Predispositions.

Authors:  Itsuro Kazama; Chieko Miura; Toshiyuki Nakajima
Journal:  Am J Case Rep       Date:  2016-02-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.